Literature DB >> 23292181

Diffusion tensor imaging and brain volumetry in Fabry disease patients.

Teemu Paavilainen1, Virva Lepomäki, Jani Saunavaara, Ronald Borra, Pirjo Nuutila, Ilkka Kantola, Riitta Parkkola.   

Abstract

INTRODUCTION: Fabry disease is a rare lysosomal storage disorder leading to cellular accumulation of globotriaosylceramide, especially in blood vessels. It is associated with severe early onset cerebrovascular disease and kidney and heart failure. The purpose of this study was to reveal possible disturbances in white matter integrity in Fabry disease patients using voxelwise diffusion-tensor imaging (DTI) analysis.
METHODS: Twelve Fabry disease patients, along with 13 healthy controls, underwent DTI and structural MRI. Voxel-based analysis of the DTI data was performed to assess possible differences in DTI parameters between Fabry disease patients and healthy controls. A selective region of interest analysis was performed for healthy volunteers and Fabry disease patients having a mild burden of T2-hyperintense lesions. We also measured normalised brain tissue volumes and performed a voxel-based volume analysis for grey matter.
RESULTS: Voxel-based analysis of DTI data showed areas of significantly reduced fractional anisotropy and increased mean diffusivity in patients with Fabry disease. Eight patients had a mild burden of white matter lesions on their T2 scans. Region of interest analysis on areas showing reduced fractional anisotropy in voxelwise analysis also revealed reduced fractional anisotropy values in this patient group compared to eight healthy volunteers. The brain volume analyses did not reveal significant differences between the Fabry disease patients and the controls.
CONCLUSION: These findings suggest a microstructural damage in brain white matter of Fabry disease patients, which can be revealed before excessive white matter lesions load is visible on conventional MR scans.

Entities:  

Mesh:

Year:  2013        PMID: 23292181     DOI: 10.1007/s00234-012-1131-8

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  43 in total

1.  Nonrigid registration using free-form deformations: application to breast MR images.

Authors:  D Rueckert; L I Sonoda; C Hayes; D L Hill; M O Leach; D J Hawkes
Journal:  IEEE Trans Med Imaging       Date:  1999-08       Impact factor: 10.048

2.  Normalized accurate measurement of longitudinal brain change.

Authors:  S M Smith; N De Stefano; M Jenkinson; P M Matthews
Journal:  J Comput Assist Tomogr       Date:  2001 May-Jun       Impact factor: 1.826

3.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

4.  Gender differences and age-related white matter changes of the human brain: a diffusion tensor imaging study.

Authors:  Jung-Lung Hsu; Alexander Leemans; Chyi-Huey Bai; Cheng-Hui Lee; Yuh-Feng Tsai; Hou-Chang Chiu; Wei-Hung Chen
Journal:  Neuroimage       Date:  2007-09-20       Impact factor: 6.556

5.  About "axial" and "radial" diffusivities.

Authors:  Claudia A M Wheeler-Kingshott; Mara Cercignani
Journal:  Magn Reson Med       Date:  2009-05       Impact factor: 4.668

6.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

7.  CNS manifestations of Fabry's disease.

Authors:  Andreas Fellgiebel; Matthias J Müller; Lionel Ginsberg
Journal:  Lancet Neurol       Date:  2006-09       Impact factor: 44.182

8.  Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study.

Authors:  G Tedeschi; S Bonavita; T K Banerjee; A Virta; R Schiffmann
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

9.  Homocysteine, cerebrovascular disease and brain atrophy.

Authors:  Perminder Sachdev
Journal:  J Neurol Sci       Date:  2004-11-15       Impact factor: 3.181

10.  An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia.

Authors:  Riki Okeda; Masahiro Nisihara
Journal:  Neuropathology       Date:  2008-04-11       Impact factor: 1.906

View more
  12 in total

1.  Determinants of white matter hyperintensity burden in patients with Fabry disease.

Authors:  Natalia S Rost; Lisa Cloonan; Allison S Kanakis; Kaitlin M Fitzpatrick; Danielle R Azzariti; Virginia Clarke; Charles M Lourenco; Dominique P Germain; Juan M Politei; György A Homola; Claudia Sommer; Nurcan Üçeyler; Katherine B Sims
Journal:  Neurology       Date:  2016-04-20       Impact factor: 9.910

2.  White Matter Microstructure and Subcortical Gray Matter Structure Volumes in Aspartylglucosaminuria; a 5-Year Follow-up Brain MRI Study of an Adolescent with Aspartylglucosaminuria and His Healthy Twin Brother.

Authors:  Tokola Anna; Brandstack Nina; Hakkarainen Antti; Salli Eero; Åberg Laura; Autti Taina
Journal:  JIMD Rep       Date:  2017-02-10

3.  Default mode network modifications in Fabry disease: A resting-state fMRI study with structural correlations.

Authors:  Sirio Cocozza; Giuseppe Pontillo; Mario Quarantelli; Francesco Saccà; Eleonora Riccio; Teresa Costabile; Gaia Olivo; Vincenzo Brescia Morra; Antonio Pisani; Arturo Brunetti; Enrico Tedeschi
Journal:  Hum Brain Mapp       Date:  2018-01-09       Impact factor: 5.038

4.  Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

Authors:  Sirio Cocozza; Gaia Olivo; Eleonora Riccio; Camilla Russo; Giuseppe Pontillo; Lorenzo Ugga; Silvia Migliaccio; Dario de Rosa; Sandro Feriozzi; Massimiliano Veroux; Yuri Battaglia; Daniela Concolino; Federico Pieruzzi; Antonino Tuttolomondo; Aurelio Caronia; Cinzia Valeria Russo; Roberta Lanzillo; Vincenzo Brescia Morra; Massimo Imbriaco; Arturo Brunetti; Enrico Tedeschi; Antonio Pisani
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

5.  Detecting the effects of Fabry disease in the adult human brain with diffusion tensor imaging and fast bound-pool fraction imaging.

Authors:  Hunter R Underhill; Katie Golden-Grant; Lauren T Garrett; Stefanie Uhrich; Brandon A Zielinski; C Ronald Scott
Journal:  J Magn Reson Imaging       Date:  2015-05-27       Impact factor: 4.813

6.  The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease.

Authors:  Mario Tranfa; Mario Tortora; Giuseppe Pontillo; Valentina Iuzzolino; Eleonora Riccio; Simona Caccavallo; Teodolinda Di Risi; Serena Monti; Roberta Lanzillo; Vincenzo Brescia Morra; Giuseppe Palma; Maria Petracca; Antonio Pisani; Arturo Brunetti; Sirio Cocozza
Journal:  Eur Radiol       Date:  2022-01-14       Impact factor: 5.315

Review 7.  Neuroimaging in Fabry disease: current knowledge and future directions.

Authors:  Sirio Cocozza; Camilla Russo; Giuseppe Pontillo; Antonio Pisani; Arturo Brunetti
Journal:  Insights Imaging       Date:  2018-11-02

8.  Reduced Intracranial Volume in Fabry Disease: Evidence of Abnormal Neurodevelopment?

Authors:  Giuseppe Pontillo; Sirio Cocozza; Arturo Brunetti; Vincenzo Brescia Morra; Eleonora Riccio; Camilla Russo; Francesco Saccà; Enrico Tedeschi; Antonio Pisani; Mario Quarantelli
Journal:  Front Neurol       Date:  2018-08-17       Impact factor: 4.003

9.  Microstructural damage of the cortico-striatal and thalamo-cortical fibers in Fabry disease: a diffusion MRI tractometry study.

Authors:  Sirio Cocozza; Simona Schiavi; Giuseppe Pontillo; Matteo Battocchio; Eleonora Riccio; Simona Caccavallo; Camilla Russo; Teodolinda Di Risi; Antonio Pisani; Alessandro Daducci; Arturo Brunetti
Journal:  Neuroradiology       Date:  2020-07-22       Impact factor: 2.804

10.  Altered Gene Expression in Prefrontal Cortex of a Fabry Disease Mouse Model.

Authors:  Kai K Kummer; Theodora Kalpachidou; Miodrag Mitrić; Michiel Langeslag; Michaela Kress
Journal:  Front Mol Neurosci       Date:  2018-06-25       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.